We investigated concentrations of prostate-specific antigen (PSA) in m
idstream urine of 213 patients. Among them were 34 females. Diagnoses
of the male patients were 42 benign prostatic hypertrophy (BPH), 21 lo
calized prostate cancer prior to radical prostatectomy(RP), 15 post-RP
without distant or local recurrence, 5 post-RP with local recurrence
and 82 with other urological diseases. PSA levels were determined by t
he Hybritech Tandem E method. Female urine samples were positive in 38
% of the cases. This and the finding of PSA in urine of men after RP i
s most likely due to extraprostatic production by periurethral glands.
Urinary PSA levels do not differ between patients with BPH, organ-con
fined prostate cancer and other diagnoses. In some cases, however, uri
ne PSA levels can be elevated in men with local tumor recurrence after
RP when serum levels are still undetectably low. This indicates that
the determination of urinary PSA concentration might be useful in the
follow-up of patients after RP.